Risk of GI Endoscopy Complications Higher than Previously Reported
Complications after gastrointestinal endoscopies appear to be higher than previous estimates. However, most of the problems are minor and the rate of serious complications is lower than previously anticipated, a study in this week's Archives of Internal Medicine shows.
The overall risk of complications was two to three times higher than had been reported. However, the risk of severe complications such as perforations and bleeding, heart attacks or even death, were lower than previous studies by about half, says study author Daniel Leffler, MD, director of clinical research at the Celiac Center at Beth Israel Deaconess Medical Center in Boston.
Leffler says electronic medical records might emerge as a better way to track complications from different hospital procedures.
About 15 million to 20 million GI endoscopic procedures are performed each year in the U.S. In this study, Beth Israel Deaconess Medical Center's electronic medical records were used to monitor emergency department visits and hospitalizations of patients who had had an endoscopy within the past two weeks. Previous research shows that most post-endoscopy-related hospital visits occur within two weeks after the procedure.
The system recorded 6,383 endoscopies and 11,632 colonoscopies between March 1 and Nov. 30, 2007. A total of 419 ED visits and 266 hospitalizations took place within two weeks following the procedures. Of these, 134 (32%) ED visits were related to complications related to the endoscopies, as were 76 (29%) of the hospitalizations. Traditional reporting by physicians recorded only 31 such complications, the study shows.
- How Top-Ranked MA Plans Earn Their Stars
- Readmissions: No Quick Fix to Costly Hospital Challenge
- How Hospitals Can Become 'Upstreamists'
- 4 Ways to Lower the Cost to Collect from Self-Pay Patients
- House Calls Key to Pioneer ACO Success
- How Telehealth Pays Off for Providers, Patients
- 4 Tips for Managing Employed Physicians
- Defensive Medicine Still Prevalent Despite Tort Reform
- WellPoint Dominates Nearly Half of Markets, AMA Says
- 'Overtreatment' Debate Circles Back to Lung Cancer Screening